Massuti B, Dols MC, Rodriguez-Paniagua M, et al. SCAT Ph III Trial: Adjuvant CT Based on BRCA1 Levels in NSCLC N+ Resected Patients. Final Survival Results a Spanish Lung Cancer Group Trial. 18th World Conference on Lung Cancer (WCLC) 2017, abstract PL 02.04.
Veel nieuwe behandelopties verwacht bij behandeling urotheelcelcarcinoom
nov 2019 | Immuuntherapie, Uro-oncologie